ArticleCancer communications (London, England)2025

Neoadjuvant chemotherapy plus anlotinib in the treatment of resectable head and neck squamous cell carcinoma: A pilot phase II trial.

Qianting He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.